Selected Publications

Hundley WW, O'Connell NS, Kirkman DL, Olson KC, Reding KW, Ky B, Ruddy KJ, Lesser GJ, D'Agostino RB Jr, Hundley WG, Bellissimo MP.: Statins to reduce renal sinus fat among breast cancer patients undergoing anthracycline-based chemotherapy: A substudy of PREVENT-WF-98213. PLoS One 20: e0318017, Sep 2025.

Juhasz V, Drobni ZD, Quinaglia T, Gilman HK, Suero-Abreu GA, Ghamari A, Heemelaar JC, Neuberg DS, Han Y, Ky B, Kwong RY, Januzzi JL, Asnani A, Mousavi N, Redd RA, Jerosch-Herold M, Scherrer-Crosbie M, Neilan TG.: Atorvastatin and Left Atrial Function During Anthracycline-based Chemotherapy. J Cardiovasc Magn Reson Aug 2025.

Meng X, Eulalio T, Kim Y, Easton J, Mulder HL, Walker E, Neale G, Song N, Shelton K, Howell RM, Xing M, Mirzaei S, Srivastava DK, Ky B, Dixon SB, Hudson MM, Ness KK, Armstrong GT, Wang Z.: Epigenetic Age Acceleration Mediates Treatment Effects on Cardiometabolic and Cardiovascular Risk in Childhood Cancer Survivors. JACC CardioOncol Jun 2025.

Berkman AM, Liu Q, Yasui Y, Grishman E, Ehrhardt MJ, Ky B, Rhea IB, Delaney A, Wilson CL, Ware M, Ness KK, Armstrong GT, Hudson MM, Dixon SB.: Cardiometabolic outcomes after bariatric surgery in adult survivors of childhood cancer: a SJLIFE report. J Natl Cancer Inst Jun 2025.

Barrett MA, Demissei BG, Hu R, Smith AM, Freedman G, Plastaras J, Feigenberg S, Berlin E, Narayan HK, Lefebvre B, Crosbie MS, Fradley M, Carver J, Chen J, Ky B.: 3D Echocardiographic Phenotyping of Left Ventricular Mechanics and Function With Contemporary Radiation Therapy. Adv Radiat Oncol 10: 101786, Apr 2025.

Fanaroff AC, Orr JA, Anucha C, Kim E, Rareshide C, Echevarria M, Rodarte S, Kassabian M, Balasian E, Ky B, Volpp KGM, Armenian S. : A randomized controlled trial of gamification to increase physical activity among black and Hispanic breast and prostate cancer survivors: Rationale and design of the ALLSTAR clinical trial. Am Heart J 280: 42-51, February 2025 Notes: Epub 2024 Nov 4.

Sutton AL, O'Connell NS, Lucas AR, Olson KC, Reding KW, Sheppard VB, Ky B, Ruddy KJ, Weaver KE, Hundley WG.: Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213). Cardiooncology 11: 11, Feb 2025.

Daniel L, Bellissimo MP, D'Agostino RB Jr, Olson KC, Ladd AC, Reding KW, Weaver KE, Lesser GJ, Ky B, Hundley WG; UPBEAT Study Team.: Intermuscular Fat and Physical Activity Levels Relative to Exercise Capacity Change During Breast Cancer Treatment. JACC CardioOncol 2025.

Jung W, Hubbard RA, Smith AM, Ko K, Huang A, Wang J, Isaacs JM, Zhang L, Liu PP, Chen Z, Shah PD, Mintzer D, Bhattacharya S, Knollman HM, Clark AS, Koropeckyj-Cox D, Messinger M, Wilcox NS, Xia C, Narayan V, Upshaw JN, Armenian SH, Ky B.: Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial. Breast Cancer Res Treat 2025.

Anderson E, Choi Y, Buchsbaum RJ, Klein A, Ky B, Landsburg D, Durani U, Ruddy KJ, Yu AF, Leong D, Asnani A, Neilan TG, Ganatra S, Bloom M, Barac A, Yang EH, Deswal A, Cheng RK, Weiss M, Evens AM, Kahl B, Friedberg JW, Parsons SK, Upshaw JN.: Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure. Leuk Lymphoma 2025.